BUFFALO, NY — June 5, 2026 — A new review was published in Volume 18 of Aging on May 15, 2026, titled “Blue period – features of senescence 30 years after beta-galactosidase.”

A new study shows that maintaining favorable lifestyle and health conditions effectively mitigates dementia risk for APOE ε4 noncarriers and heterozygotes, validating population-based public health interventions targeting modifiable risk factors. Conversely, the persistently high risk in homozygotes, regardless of lifestyle, underscores the need for personalized precision prevention alongside these broad public health efforts.

The DIVINE cohort brings together clinical data from 5,813 patients hospitalised with COVID-19 during the first four waves of the pandemic and makes it available to the scientific community through an open, accessible and reusable resource. Published in Scientific Data, this multicentre database has already contributed to several studies and aims to support further research into the clinical progression of COVID-19, associated risk factors and the development of predictive models.

Biophotonics refers to the development and application of light-based technologies to study biological systems. The application of terahertz (THz) frequency range in biophotonics is considered a promising avenue for advancing biological research. However, several challenges still limit practical adoption, although recent developments show strong potential. In a new study, researchers present a comprehensive review of recent advancements and emerging applications of THz biophotonics, highlighting promising areas and future research directions that can expand its adoption.

Researchers at Yokohama City University, Japan, have uncovered evidence that the Y chromosome gene UTY still retains regulatory activity in human embryonic stem cells, offering a rare glimpse into what may represent an evolutionary transitional state of the human Y chromosome.